Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland

H Freimann; A Calderoni; P Cornu; R Olie

doi:10.4414/smw.2007.11716

Original article

Vol. 137 No. 2122 (2007)

Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland

H Freimann
A Calderoni
P Cornu
R Olie

Fulltext PDF

Cite this as:: Swiss Med Wkly. 2007;137:317-322
Published: 02.06.2007

How to Cite

1.

Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland. Swiss Med Wkly [Internet]. 2007 Jun. 2 [cited 2025 Oct. 17];137(2122):317-22. Available from: https://smw.ch/index.php/smw/article/view/736

Share

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

DOI:: https://doi.org/10.4414/smw.2007.11716